Informationen:
Fehler:
ID
34047
Beschreibung
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson`s Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02224664
Link
https://clinicaltrials.gov/show/NCT02224664
Stichworte
Versionen (1)
- 12.01.19 12.01.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
12. Januar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Parkinson`s Disease NCT02224664
Eligibility Parkinson`s Disease NCT02224664
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Parkinson`s Disease NCT02224664
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Parkinson Disease | Characteristics Main Quantity | Tremor | Rigidity | Bradykinesia
Item
clinical diagnosis of idiopathic parkinson's disease with at least 2 out of 3 cardinal characteristics (tremor, rigidity, bradykinesia)
boolean
C0030567 (UMLS CUI [1])
C1521970 (UMLS CUI [2,1])
C1542147 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0040822 (UMLS CUI [3])
C0026837 (UMLS CUI [4])
C0233565 (UMLS CUI [5])
C1521970 (UMLS CUI [2,1])
C1542147 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0040822 (UMLS CUI [3])
C0026837 (UMLS CUI [4])
C0233565 (UMLS CUI [5])
Mini-mental state examination
Item
mini-mental state examination (mmse) ≥ 25
boolean
C0451306 (UMLS CUI [1])
Hoehn and Yahr Stage
Item
hoehn & yahr stage i-iii inclusive
boolean
C3639483 (UMLS CUI [1])
End Levodopa Wearing off
Item
documented history of end of l-dopa wearing off
boolean
C2746065 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
C1504539 (UMLS CUI [1,3])
C0023570 (UMLS CUI [1,2])
C1504539 (UMLS CUI [1,3])
Dyskinesia Following Levodopa Dosage | MDS-UPDRS - Functional Impact of Dyskinesias
Item
cohort 5 only: history of dyskinesia following l-dopa dosing and score of at least 2 on part iv, item 4.2 (functional impact of dyskinesia) of the mds-updrs
boolean
C0013384 (UMLS CUI [1,1])
C0332282 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,4])
C3639485 (UMLS CUI [2])
C0332282 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,4])
C3639485 (UMLS CUI [2])
Atypical Parkinsonism | Secondary Parkinson Disease
Item
atypical/secondary parkinsonism
boolean
C4302185 (UMLS CUI [1])
C0030569 (UMLS CUI [2])
C0030569 (UMLS CUI [2])
Surgical intervention Parkinson Disease
Item
history of surgical intervention for parkinson's disease
boolean
C0549433 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,2])
Dementia Interferes with Clinical Trial Assessment | Impaired cognition Interferes with Clinical Trial Assessment
Item
dementia/cognitive impairment that can interfere with study assessments
boolean
C0497327 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1516048 (UMLS CUI [1,4])
C0338656 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C1516048 (UMLS CUI [2,4])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1516048 (UMLS CUI [1,4])
C0338656 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C1516048 (UMLS CUI [2,4])